vs

Side-by-side financial comparison of QUHUO Ltd (QH) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $157.9M, roughly 1.3× QUHUO Ltd).

QUHUO Ltd. operates an on-demand lifestyle service platform focused on the Chinese mainland market. Its core offerings include gig workforce solutions, community group-buy services, and local life service matching for merchants and individual users, covering household services, catering operation support, and community retail segments to effectively connect service providers with end consumers.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

QH vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$157.9M
QH

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
QH
QH
RGEN
RGEN
Revenue
$157.9M
$197.9M
Net Profit
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QH
QH
RGEN
RGEN
Q4 25
$197.9M
Q3 25
$188.8M
Q2 25
$157.9M
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$222.9M
$154.1M
Q1 24
$151.3M
Net Profit
QH
QH
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$14.9M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$-6.4M
$3.3M
Q1 24
$2.1M
Gross Margin
QH
QH
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
1.5%
49.8%
Q1 24
49.5%
Operating Margin
QH
QH
RGEN
RGEN
Q4 25
9.0%
Q3 25
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
-2.7%
1.0%
Q1 24
1.3%
Net Margin
QH
QH
RGEN
RGEN
Q4 25
6.7%
Q3 25
7.9%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
-2.9%
2.2%
Q1 24
1.4%
EPS (diluted)
QH
QH
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QH
QH
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$4.3M
$767.6M
Total DebtLower is stronger
$858.0K
$542.2M
Stockholders' EquityBook value
$57.4M
$2.1B
Total Assets
$118.4M
$2.9B
Debt / EquityLower = less leverage
0.01×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QH
QH
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$4.3M
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$14.3M
$809.1M
Q1 24
$780.6M
Total Debt
QH
QH
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
$858.0K
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
$1.2M
Q1 24
Stockholders' Equity
QH
QH
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$57.4M
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$64.6M
$2.0B
Q1 24
$2.0B
Total Assets
QH
QH
RGEN
RGEN
Q4 25
$2.9B
Q3 25
$2.9B
Q2 25
$118.4M
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$135.0M
$2.9B
Q1 24
$2.8B
Debt / Equity
QH
QH
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
0.01×
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QH
QH
RGEN
RGEN
Operating Cash FlowLast quarter
$-5.8M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QH
QH
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$48.1M
Q2 25
$-5.8M
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
QH
QH
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
QH
QH
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
QH
QH
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
QH
QH
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons